Hanaoka Shunsuke, Iwabuchi Kaede, Hirai Toshiyuki, Seki Toshiichi, Hayashi Hiroyuki
Laboratory of Pharmacotherapy, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi-shi, Chiba 274-8555, Japan.
Department of Pharmacy, Hitachi, Ltd. Hitachinaka General Hospital, 20-1, Ishikawa-cho, Hitachinaka-shi, Ibaraki 312-0057, Japan.
Stroke Res Treat. 2024 Dec 13;2024:2381790. doi: 10.1155/srat/2381790. eCollection 2024.
Polypharmacy is a predictor of adverse outcomes, making its management crucial for improving patient health and recovery. Managing polypharmacy is particularly challenging in patients with stroke with many comorbidities and sequelae. Although reducing inappropriate prescribing is necessary, the number of medications may increase to effectively implement secondary prevention, potentially offsetting any changes in medication count. For patients with stroke undergoing recovery-phase rehabilitation, balancing secondary prevention and optimizing drug use early without hindering recovery of activities of daily living are crucial. This study is aimed at examining the effect of increasing or decreasing the use of polypharmacy on recovery of motor and cognitive function during recovery-phase rehabilitation in patients with stroke. The study was conducted from July 2010 to June 2019 among patients with stroke discharged from the convalescent rehabilitation ward during the study period. Patients who were using more than five drugs on admission and had either an increase or decrease in the number of drugs used on discharge were compared. Propensity score matching (PSM) was used to control for background variables such as patient demographics, laboratory values, and functional independence measure (FIM) scores at baseline. The primary outcomes were motor, cognition, and total FIM gain. Of the 226 patients initially enrolled, 156 were matched on propensity score. The total motor FIM gain, total cognitive FIM gain, and total FIM gain were significantly higher in the decreased group than in the increased group ( = 0.0139, = 0.0377, and = 0.0077, respectively). : In patients with stroke, reducing rather than increasing the number of drugs administered during recovery-phase rehabilitation could improve rehabilitation outcomes. Therefore, it is important to consider whether the drugs are essential for the patient and proactively revise the drug regimen to ensure rapid rehabilitation of patients with stroke.
多重用药是不良结局的一个预测因素,因此对其进行管理对于改善患者健康和康复至关重要。在患有多种合并症和后遗症的中风患者中,管理多重用药尤其具有挑战性。虽然减少不适当的处方是必要的,但为了有效实施二级预防,药物数量可能会增加,这可能会抵消用药数量的任何变化。对于正在进行康复期康复的中风患者,在不阻碍日常生活活动恢复的情况下,平衡二级预防和尽早优化药物使用至关重要。本研究旨在探讨在中风患者康复期康复过程中增加或减少多重用药的使用对运动和认知功能恢复的影响。该研究于2010年7月至2019年6月期间在研究期间从康复病房出院的中风患者中进行。比较了入院时使用五种以上药物且出院时用药数量增加或减少的患者。倾向得分匹配(PSM)用于控制背景变量,如患者人口统计学、实验室值和基线时的功能独立性测量(FIM)分数。主要结局是运动、认知和FIM总分的改善。在最初纳入的226例患者中,156例在倾向得分上进行了匹配。减少组的总运动FIM改善、总认知FIM改善和总FIM改善均显著高于增加组(分别为 = 0.0139、 = 0.0377和 = 0.0077)。结论:在中风患者中,在康复期康复过程中减少而非增加用药数量可改善康复结局。因此,重要的是要考虑药物对患者是否必不可少,并积极修改药物治疗方案,以确保中风患者快速康复。